Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2019
Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)Sarmad Sadeghi, Susan G Groshen, Denice D Tsao-Wei, et al.Cancer Management and Research|September 7, 2023
Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic StatusMatthew M Mirsky, Carley Mitchell, Augustine Hong, et al.Cancer Research|January 29, 2015
Treatment of Invasive Brain Tumors Using a Chain-like NanoparticlePubudu M Peiris, Aaron Abramowski, James Mcginnity, et al.Research Square|July 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancerAndrew Armstrong, Tara Seibert, Jane McKenzie, et al.Cancers|January 27, 2021
Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate CancerXinning Wang, Aditi Shirke, Ethan Walker, et al.JAMA Oncology|August 26, 2021
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical TrialSumanta K Pal, Paul H Frankel, Amir Mortazavi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2021
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)Jonathan E Rosenberg, Karla A Ballman, Susan Halabi, et al.British Journal of Cancer|May 17, 2018
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)Jonathan E Rosenberg, Noah M Hahn, Meredith M Regan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and BiomarkersHimisha Beltran, Clara Oromendia, Daniel C Danila, et al.Pageof 3